NL-OMON27943尚未招募不适用
Raloxifene Augmentation in Patients with a Schizophrenia spectrum Disorder to reduce symptoms and improve cognition
MC Utrecht0 个研究点目标入组 148 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 148
研究概览
简要总结
Heringa, Sophie M., Marieke JH Begemann, Angelique J. Goverde, and Iris EC Sommer. "Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review." Schizophrenia research (2015).
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A DSM-IV-R diagnosis of: 295.x (schizophrenia, schizophreniform disorder, schizoaffective disorder, or psychotic disorder NOS)
- •- Capable of understanding the purpose and details of the study in order to provide written informed consent;
排除标准
- •- Pre-existing cardiovascular disease;
- •- History of thrombo-embolic events;
研究者
相似试验
已完成
3 期
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderSchizophreniform DisorderPsychosis NOSSchizophreniaSchizoaffective DisorderNCT03043820Iris Sommer110
已完成
3 期
Raloxifene augmentation in patients with a schizophrenia spectrum disorder to reduce symptoms and improve cognitioschizophreniaschizoaffective disorderNL-OMON55630Psychiatrie95
进行中（未招募）
1 期
Raloxifene in patients with a schizophrenia spectrum disorderEUCTR2015-004483-11-BEniversity Medical Center Utrecht154
进行中（未招募）
1 期
Raloxifene in patients with a schizophrenia spectrum disorderEUCTR2015-004483-11-NLniversity Medical Center Utrecht154
招募中
4 期
Bazedoxifene -Treatment for Women With SchizophreniaSchizophreniform DisordersSchizo Affective DisorderSchizophreniaNCT04113993The Alfred160